Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Glioblastoma 2Spondylitis, Ankylosing 1Signs and Symptoms 1Lymphoma 1Leukemia, Myeloid, Acute 1Glioma 1Epilepsy 1Diarrhea 1Colorectal Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Arthritis, Rheumatoid 1

Interventions

Octreotide 6Irinotecan 6Loperamide 5Probiotics 3Leucovorin 3Fluorouracil 3Fecal Microbiota Transplantation 3Calcium Aluminosilicate 3maltodextrin 2telotristat ethyl 1shosaiko-to 1lanreotide 1isatuximab 1ceterizine hydrochloride 1capivasertib 1cabazitaxel 1bile acid binding proteins 1XRP6258 1Theophylline 1Temozolomide 1Surveys and Questionnaires 1Sulfasalazine 1Sugars 1Standard of Care 1Raloxifene Hydrochloride 1Radiation 1Prednisone 1PHY 906 1Oxaliplatin 1Long-Term Synaptic Depression 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Diarrhea × Sulfasalazine × Clear all
NCT01198145 2020-05-12

Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
87 enrolled 11 charts

Diarrhea

Data powered by HemOnc (CC BY 4.0) Colophon âš¡